Your thyroid runs the metabolic tempo of nearly every system in your body, from heart rhythm to body weight to mood. Most of the thyroid hormone in your blood is stuck to carrier proteins and biologically inert. Only the small unbound fraction actually does anything, and that is what the Free T4 Index (FTI) is designed to estimate.
FTI is a calculation that adjusts your total thyroid hormone for changes in those carrier proteins, which can swing widely with pregnancy, oral estrogen, liver disease, or genetic differences. When binding proteins shift, total T4 can mislead. FTI tries to correct for that, giving you a cleaner read on what your tissues are actually receiving.
FTI (Free T4 Index) combines a total T4 measurement with a separate test of how much capacity your blood has to bind thyroid hormone. The most common version multiplies total T4 by a T3 uptake result. Other versions use a thyroxine-binding globulin (TBG) measurement instead. The output is a single number meant to track the unbound, biologically active fraction of thyroxine (T4).
This matters because total T4 alone can look high or low for reasons that have nothing to do with your thyroid. Pregnancy and oral estrogen raise binding proteins, which raises total T4 without changing free hormone. Severe illness or certain genetic conditions can drop binding proteins and pull total T4 down. FTI cancels out most of this noise.
Free thyroxine, which FTI estimates, is closely tied to how your tissues function. Across many clinical parameters, free T4 levels correlate with outcomes more often than TSH does. In one large analysis, clinical parameters were significantly associated with free T4 in 50% of cases, compared to 23% for TSH. That makes the active hormone signal a meaningful target on its own, not just a downstream check on your pituitary.
Higher free T4, even within the normal range, raises your risk of atrial fibrillation. A study of 174,914 adults found that higher free thyroxine levels within the standard reference range predicted a meaningfully increased risk of atrial fibrillation. A separate review of euthyroid people confirmed that higher free T4, but not TSH, was associated with incident atrial fibrillation. Higher free T4 has also been linked to ischemic heart disease and hypertension in cohorts where TSH and free T4 were both technically normal.
In a study of 1,801 elderly men, higher serum free T4 was associated with increased mortality and cerebrovascular events, while TSH levels were not. The signal in your circulating thyroid hormone often gets to the answer before your pituitary does.
Lower-normal free T4 also carries risk. In a Chinese cohort of 2,694 adults, free T4 at or below 16.0 pmol/L independently predicted higher rates of metabolic syndrome. The combination of lower free T4 and higher-normal TSH (above 2.0 mIU/L) carried the highest risk. Composite indices that combine free T4 and TSH (sometimes called thyroid sensitivity or feedback indices) have linked impaired thyroid feedback to type 2 diabetes, ischemic heart disease, atrial fibrillation, hypertension, and obesity in a study of 7,391 adults.
In a cohort of 517,996 adults, free T4 below the reference range was linked to roughly twice the risk of liver cancer mortality. Even within the normal range, lower free T4 values showed a step-wise increase in liver cancer death risk. The mechanism is not fully worked out, but the dose-response pattern is consistent.
In the first trimester, isolated low free T4 (with normal TSH) was associated with macrosomia, where the baby grows larger than expected. In a Chinese prospective cohort of 1,236 pregnant women, the risk of macrosomia rose as free T4 fell, even when TSH was normal. This is one of the situations where FTI specifically outperforms direct free T4 immunoassays, because pregnancy dramatically changes binding protein levels and can distort direct free T4 measurements.
In ICU populations, both low free T3 and low free T4 are linked to higher short-term mortality. In a study of 888 severely ill adults, very low free T4 (below approximately 1.2 µg/dL) marked a sharp increase in 30-day death risk. In COVID-19, low free T4 paired with low TSH was associated with higher mortality and disease severity. These findings reflect a phenomenon called nonthyroidal illness, where the thyroid axis dampens during severe illness.
FTI does not have a universal cutpoint. The number depends heavily on which assay your lab uses, including whether they use T3 uptake or a direct TBG measurement. The ranges below come from published research and are illustrative orientation only. Your lab will likely report different numbers in different units, and the most useful comparison is your own results within the same lab over time.
| Tier | Interpretation | What It Suggests |
|---|---|---|
| Low FTI | Below your lab's reference range | Possible hypothyroidism, nonthyroidal illness, or central hypothyroidism if TSH is also low or normal |
| Normal FTI | Within your lab's reference range | Thyroid hormone supply to tissues is in the expected range; pair with TSH for full context |
| High FTI | Above your lab's reference range | Possible hyperthyroidism or thyroiditis; even high-normal values associate with atrial fibrillation risk |
Compare your FTI within the same lab over time. Different assays produce different numbers, and a value that looks high at one lab may be normal at another. The trend in your own data matters more than where you fall on any single reference scale.
Thyroid biology has a personal set point. Studies of healthy people show that each individual sits within a narrow range of total and free thyroid hormone values, and that range is much narrower than the population reference interval. This means a single FTI result can sit comfortably in the normal range while still being abnormal for you. The only way to spot that is serial measurement.
Get a baseline. If you are starting or adjusting thyroid medication, retest in 6 to 8 weeks. If you are tracking thyroid health proactively without symptoms, retest annually. Pair every FTI with TSH so you can see whether your pituitary feedback agrees with your peripheral hormone levels. When the two disagree, that pattern is itself diagnostic information.
FTI handles binding protein changes better than total T4, but it is not bulletproof. A few situations can throw the number off without reflecting your true thyroid status.
Some medications change FTI without causing thyroid disease. Knowing this prevents unnecessary worry and unnecessary testing. GLP-1 receptor agonists (the medications used for diabetes and weight loss) have been associated with small decreases in free T4 within the normal range over about 12 months, with no clear evidence of thyroid dysfunction. Metformin lowers TSH in people who already have hypothyroidism but does not meaningfully change free T4 in either hypothyroid or healthy adults. Corticosteroids can shift T4 to T3 conversion temporarily.
FTI alone does not diagnose thyroid disease. The companion test is TSH, and the pattern of the two tells the story. High FTI with low TSH points toward hyperthyroidism. Low FTI with high TSH points toward primary hypothyroidism. Low FTI with low or normal TSH raises the question of central (pituitary-driven) hypothyroidism, which is rarer but important. Discordant results, where the two tests disagree, often reflect medications, illness, or assay interference, and warrant retesting and additional workup.
If your FTI is consistently abnormal, expand the workup. Add free T3 to assess conversion and severity. Add thyroid antibodies (anti-TPO and thyroglobulin antibodies) to look for autoimmune causes. If you are pregnant or planning pregnancy, work with an endocrinologist who uses trimester-specific reference ranges. If your FTI and TSH disagree in a way that does not fit any common pattern, ask about assay interference, which can produce false results in some immunoassays.
Evidence-backed interventions that affect your Free T4 Index level
Free T4 Index is best interpreted alongside these tests.